Besides Th1 cells, IL-17-producing Th17 cells may also have potent anti-tumor immune effects by recruiting immune cells into tumors, activating effector CD8+ T cells, or even directly by converting toward Th1 phenotype and producing IFN-γ (70, 71). This evidence concerns the gene CD8A and neoplasm.